SNCA and Parkinson disease: Applying the system to human-induced pluripotent stem cell (hiPSC)-derived dopaminergic neurons from a PD patient with the SNCA triplication, we found a significant downregulation of SNCA mRNA and protein as a result of targeted DNA methylation at intron 1.